SEI Investments’s Starling Oncology STLN Stock Holding History

SEI Investments’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-111,553	Closed	-$397K	–	3334
2025 Q4	$397K	Buy	+111,553	New	+$414K	﹤0.01%	2609

Other funds holding STLN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments's STLN Position: Q1 2026 in Review

SEI Investments sold out of Starling Oncology (STLN) in Q1 2026, closing a stake of 111,553 shares — an estimated $397K sold.

SEI Investments first reported a position in STLN in Q4 2025 and held it in 1 quarter. The position peaked at $397K in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

SEI Investments reported no remaining Starling Oncology position as of Q1 2026 after selling out during the quarter.
SEI Investments sold 111,553 Starling Oncology shares in Q1 2026, an estimated $397K.
SEI Investments first reported a position in Starling Oncology in Q4 2025 and held it in 1 quarter.
SEI Investments's Starling Oncology position peaked at $397K in Q4 2025.
115 funds tracked by Wall St. Rank held Starling Oncology as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.